Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 June 2004, Vol. 103, No. 12, pp. 4379-4380.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stacker, S. A.
Right arrow Articles by Achen, M. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Stacker, S. A.
Right arrow Articles by Achen, M. G.
Related Collections
Right arrowRelated Articles in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow


InsideBlood

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY

VEGF receptors branch into new areas

GoVascular endothelial growth factors (VEGFs) and their receptors drive key signaling pathways for the generation of new vascular structures in the developing embryo and in various pathologic conditions, including cancer. Although the ligands (VEGF-A, VEGF-B, VEGF-C, VEGF-D, and placenta growth factor) and cell surface receptors (VEGFR-1/fms-related tyrosine kinase [flt], VEGFR-2/fetal liver kinase-1 [flk-1], and VEGFR-3/flt-4; coreceptors neuropilin-1 and -2 [NP-1 and NP-2]) are well known, knowledge about their precise roles in signaling for the complexity of vascular structures is constantly evolving. VEGF-A signals through both receptor tyrosine kinases, VEGFR-1 and VEGFR-2. The latter has historically been seen as the most important for promoting angiogenesis, due to its key role in endothelial cell proliferation and chemotaxis. The role of VEGFR-1 has proven to be more elusive. Adding to the complexity of VEGFR-1 function is the production of an mRNA splice variant that encodes a secreted form of the VEGFR-1 extracellular domain (sflt-1).


In this issue, Kearney and colleagues (page 4527) use Vegfr-1 null mice and the elegant technique of confocal time-lapse imaging to examine the dynamics of vascular sprout formation in order to test a role for VEGFR-1 in VEGF-induced endothelial cell migration. Their experiments reported here do indeed show decreased sprouts and reduced migration rate in differentiated Vegfr-1-/- vessels. Perhaps the most surprising finding is the capacity of an sflt-1 transgene to rescue the mutant phenotype. The implication is that sflt-1 can bind local VEGF-A and alter the concentration gradient of this growth factor, which drives both sprouting and endothelial cell migration.

This elaborate system of ligand acting in concert with cell-bound receptor and soluble ectodomain could be a paradigm for understanding other signaling systems in which soluble ligand binding domains are involved. One clear example raised by Kearney et al is the Wnt family of receptors and ligands in which both membrane-bound and soluble receptor forms exist. The variants generated by proteolytic cleavage of receptors also add to the puzzle, guaranteeing plenty of work in the future for biochemists and biologists seeking to resolve these issues.

A critical challenge for clarifying the biologic role of different VEGF receptor complexes is to identify the downstream genes influenced by such signaling and to associate these genes with the various steps involved in angiogenesis and vasculogenesis (eg, mitogenesis, chemotaxis, migration, tube formation, and enhancement of vascular permeability). To this end, Zippo and colleagues (page 4536) have used a comparative microarray analysis of Vegfr-2 wild-type (+/+) and -/- embryonic stem (ES) cells to identify downstream transcription targets of VEGFR-2 signaling. The screen has revealed that Pim-1, a gene encoding a serine/threonine kinase, plays a role in the differentiation of ES cells to endothelial cells and smooth muscle cells and may thereby play a role in early vascular development. Furthermore, Pim-1 appears to be required for VEGF-A-dependent proliferation and migration of endothelial cells. Another study recently prepublished in Blood identified a VEGF-A target gene called DSCR1 that regulates the expression of inflammatory markers in endothelial cells.1Go


These studies illustrate just how many layers of the vascular signaling pathways need to be uncovered. While much work remains to be done on ligand/receptor interactions in the extracellular milieu and at the cell surface, studies of events in the nucleus are only just beginning.

--- Steven A. Stacker, and Marc G. Achen
Ludwig Institute for Cancer Research

References

  1. Hesser BA, Liang XH, Camenisch G, et al. Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells. Blood. Prepublished March 11, 2004; DOI 10.1182/blood-2004-01-0273.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Articles in Blood Online:

The VEGF receptor flt-1 (VEGFR-1) is a positive modulator of vascular sprout formation and branching morphogenesis
Joseph B. Kearney, Nicholas C. Kappas, Catharina Ellerstrom, Frank W. DiPaola, and Victoria L. Bautch
Blood 2004 103: 4527-4535. [Abstract] [Full Text] [PDF]

Identification of Flk-1 target genes in vasculogenesis: Pim-1 is required for endothelial and mural cell differentiation in vitro
Alessio Zippo, Alessandra De Robertis, Monia Bardelli, Federico Galvagni, and Salvatore Oliviero
Blood 2004 103: 4536-4544. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stacker, S. A.
Right arrow Articles by Achen, M. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Stacker, S. A.
Right arrow Articles by Achen, M. G.
Related Collections
Right arrowRelated Articles in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020